FiledMay 2026
Intellectual property
ICC files a patent pending for terpenes
This filing marks ICC's latest milestone as the company continues developing proprietary terpene formulations for future product work.
Milestones
The current ICC milestone roadmap.
ICC's current milestone centers on patent-pending terpene formulation work and continued progress toward proprietary cannabis product development.
Milestones
Latest milestone
ICC's latest milestone centers on formulation IP and the company's continued development work around practical cannabis innovation.
Latest milestone
Patent-pending terpene formulation.
Filed in May 2026, this milestone supports ICC's long-term product development and formulation roadmap.
New Press Release
ICC advances terpene-based research for anxiety relief
ICC is exploring terpene-derived botanical pathways through research focused on stress, mood, mental balance, and the future of evidence-based anxiety care.
Next step
Read the latest release.
The press release section keeps the newest public ICC update connected to the broader company story.
View news